Heather Raymon
Corporate Officer/Principal bij Artiva Biotherapeutics, Inc.
Profiel
Heather Raymon is currently the SVP-Research & Early Development at Artiva Biotherapeutics, Inc. Prior to this, she worked as the Executive Director-Early Development Program at Bristol Myers Squibb Co. and as the Senior Director & Head-Pharmacology at Celgene Corp.
Dr. Raymon received her undergraduate degree from the State University of New York at Albany and her doctorate degree from the University of California, Irvine.
Actieve functies van Heather Raymon
Bedrijven | Functie | Begin |
---|---|---|
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01-10-2020 |
Eerdere bekende functies van Heather Raymon
Bedrijven | Functie | Einde |
---|---|---|
CELGENE | Corporate Officer/Principal | - |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
Opleiding van Heather Raymon
State University of New York at Albany | Undergraduate Degree |
University of California, Irvine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. BiotechnologyHealth Technology Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA. | Health Technology |
Celgene Corp.
Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |